Home

Amy L. Burroughs

CIK 1872564 · Chief Executive Officer · last filed 2026-05-29

Amy L. Burroughs is a Chief Executive Officer who has filed 20 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for TNYA, was dated May 29, 2026. Across all open-market trades the lifetime net is −$6.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $486.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$486.6K

Companies

3

Total Filings

20

Lifetime Open-Market Net

-$6.17M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNYA Director — $0.76 — $0 5 2026-05-29
Terns Pharmaceuticals, Inc. (TERN) Delisted Chief Executive Officer 0 $52.95 $0 -$6.32M 9 2026-05-05
DMAC Director 73,288 $6.64 $486.6K $141.6K 5 2023-01-03

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-29 TNYA Grant (A) — $0 EDGAR
2026-05-05 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed −304,933 -$16.16M EDGAR
2026-03-17 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed — -$613.4K EDGAR
2026-02-18 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed — -$503.9K EDGAR
2026-01-16 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed +150,000 -$2.23M EDGAR
2026-01-15 Terns Pharmaceuticals, Inc. (TERN) Delisted Notice (144) −97,915 -$3.64M EDGAR
2026-01-06 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed +100,212 -$2.62M EDGAR
2025-06-25 Terns Pharmaceuticals, Inc. (TERN) Delisted Buy (P) +23,314 $90.2K EDGAR
2025-05-30 TNYA Grant (A) — $0 EDGAR
2025-02-03 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed +510 $2.6K EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.